aTyr Pharma holders approve reverse stock split of 1-for-10 to 1-for-50 at Board's discretion

aTYR PHARMA INC

Proposal 1 approved: alternate charter amendments let the Board effect a reverse split at any ratio between 1-for-10 and 1-for-50, inclusive, in its sole discretion.
Vote tally: 52,451,734 for, 5,234,645 against, 228,991 abstained, no broker non-votes.
57,915,370 shares, or about 59.04% of shares outstanding, were represented at the October 16, 2026 Special Meeting.
Record date was September 4, 2026, with 98,087,425 shares of common stock outstanding and entitled to vote.
Filing does not state a split ratio, timing, or effective date; those remain subject to future Board determination.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.